Navigation Links
Study suggests brain tumors need treatment with multiple 'targeted' drugs
Date:9/13/2007

BOSTON--Researchers at Dana-Farber Cancer Institute have shown that several, rather than just one, cell-growth switches are simultaneously overactive in many brain tumors and other solid tumors, explaining why treatment with just a single "targeted" switch-blocking drug often yields disappointing results.

The laboratory finding argues for quickly moving to clinical trials that combine three or more such targeted drugs for such cancers to shut down all the malfunctioning growth switches, according to the team led by Ronald DePinho, MD, director of the Center for Applied Cancer Science at the Dana-Farber. Their report is being posted online on Sept. 13 by the journal Science and will appear in a forthcoming print issue.

The switches are formed by molecules called receptor tyrosine kinases (RTKs) that often are mutated and hyperactive in cancer cells. Since a number of kinase-blocking drugs are already available -- Gleevec and Tarceva are two of the best-known -- the researchers said clinical trials of combinations of the compounds should be planned quickly.

"This is a transformative finding that will motivate clinicians and our pharmaceutical colleagues to design clinical trials with regimens using several inhibitors," said DePinho. He noted that in the laboratory study using cancer cell lines and fresh specimens of brain tumors, three or more kinase inhibitors were needed to quell the abnormal cell-growth signals.

The study focused on glioblastoma multiforme (GBM), an aggressive brain tumor that is nearly always fatal. The scientists also found similar patterns of multiply activated RTKs in other common cancers of the pancreas and lung.

Jayne Stommel, PhD, lead author of the report and a post-doctoral fellow in the DePinho lab, undertook a survey of molecular RTK "signaling pathways" in GBM cells to find the sources of abnormal growth.

RTKs are located on the surface of both normal and cancerous cells and rec
'/>"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Rural Canadians travel far for specialists: study
2. A new study surpasses Gene Therapy Hurdle
3. Tomato Sauce reduces Cancer Risk- Study
4. A question on study of Adult Stem Cell
5. Study on obesity and heart failure
6. National Lung Study in the process
7. Marijuana gateway theory strengthened by study of twins
8. Old theory of adaptation confirmed by new study
9. Study casts doubt on keyboard ills
10. Gene study links endometriosis, infertility
11. Study reveals how stress can make you sick
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...ANTON, Calif., July 25 /PRNewswire-FirstCall/ -- T...r in device-based mechanical,circulatory support t...ts,today announced that it will report its operat...onths of fiscal 2008 on Thursday, July 31., The c...financial,results and operating activities to all ...
(Date:7/25/2008)...rtain cleaning products reduces lung function, inc... FRIDAY, July 25 (HealthDay News) -- A clean, fres...h, depending on what type of cleaning and air fres...ests that exposure to cleaning products or air fre...mpound (VOC) called 1,4 dicholorobenzene (1,4 DCB)...
(Date:7/25/2008)...OK, Ill. July 25, 2008 The American Society for...elines on the role of endoscopy in the bariatric s...n the United States and the success in surgical in... of weight-loss surgeries performed in the U.S., f...nes discuss endoscopy in the preoperative patient ...
(Date:7/25/2008)...S, July 25 /PRNewswire/ -- BeaconEquity.com announ...ing news today., Investors can view all of the da...aconEquity.com/m , Today,s Trade Alerts include: ...Brook Pharmaceuticals Inc. (Nasdaq: MBRK ), NovaM...R ), Affymetrix Inc. (Nasdaq: AFFX ) and,Abaxis I...
Breaking Medicine News(10 mins):Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2Health News:Health Hazards in Household Cleaners Exposed 2Health News:Health Hazards in Household Cleaners Exposed 3Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 3Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3
...ing out of control, 'in'? A new report by the Ame...sy with reports of college girls and their wild (s... has revealed that breaking out of control and goi...ing fun in life. Three out of four women seem to g...
...art is under pressure as it is asked to improve it...llary Rodham Clinton who has had deep// ties with ...linton served on Wal-Mart's board of directors for...er time on the board of Wal-Mart was a memorable o...
...'s joy and relief at Norfolk as surgeons at the No...ven the green signal to make available the breast/... for her-2 gene. "We made the business case and ... groups, and the primary care trusts have backed t...
...esearch by the British Heart Foundation says that ... to fall a victim to heart disease than people// o...type 2 diabetes as compared to 3 percent of the ge...ate concern are the high rates of untreated diabet...
Other Medicine News:
(Date:7/24/2008)... NEW ORLEANS, July 24 /PRNewswire-USNewswire/ --...ped for mental illnesses, according to a new,repor...ed on the,devastating effects that mental illnesse...ationwide, mental illness affects nearly 60 millio...ceutical Research and Manufacturers,of America (Ph...
(Date:7/24/2008)... Revolutionary thermometer designed to take body...Fla., July 24 /-- Kidz-Med,... Inc. Pink Sheets: ASFX),United States distributo...eter, is pleased to announce the results of a clin...ic of the University of Milan, in,Milan, Italy, wh...
(Date:7/23/2008)... - Nexavar is First Approved Systemic Therapy to... Calif., July 23 /-,Bayer H..., Inc. (Nasdaq:,ONXX) today announced that The New...a Phase 3 trial demonstrating that Nexavar(R) (sor...th by 31 percent in patients with,unresectable hep...
(Date:7/23/2008)... WASHINGTON, July 23 /PRNewswire-USNewswire/ -- ...of Justice:, Chairman Conyers, Ranking Member Smi...e opportunity to testify today., Since I appeared...ve,become even better acquainted with the talented...ment and with the work they do, and I have come to...
Breaking Medicine Technology:More Than 300 New Medicines Being Developed for Mental Illnesses 2More Than 300 New Medicines Being Developed for Mental Illnesses 3More Than 300 New Medicines Being Developed for Mental Illnesses 4Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Dr Charles A Sims of California Cryobanks Family Cord Blood Services Named to National Stem Cell Advisory Council 2703 1Dr Charles A Sims of California Cryobanks Family Cord Blood Services Named to National Stem Cell Advisory Council 2703 2Dr Charles A Sims of California Cryobanks Family Cord Blood Services Named to National Stem Cell Advisory Council 2703 3Tasker Products to Showcase Tasker Blue at International Poultry Expo 2698 1Tasker Products to Showcase Tasker Blue at International Poultry Expo 2698 2Tasker Products to Showcase Tasker Blue at International Poultry Expo 2698 3Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer 1250 1Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer 1250 2Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer 1250 3Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer 1250 4Researchers identify brains eureka circuitry 9955 1Researchers identify brains eureka circuitry 9955 2
...ntent Editor Medcompare.com ,According to a...oint United Nations Programme on HIV/AIDS) and the...iving with HIV globally reached an estimated high ...n deaths caused by AIDS. The latest data from the...illion people in the United States are now living ...
...T (ASCP), MA Ed ,Contributing Editor , ,Po...by healthcare accrediting bodies for the past few ...hardware and software were beyond the reach of the...multiple vendors with devices that can be integrat...me systems are better for small facilities, while ...
Other Medicine Technology:Rapid HIV Testing Increases Possibility of Treatment 2Rapid HIV Testing Increases Possibility of Treatment 3Managing Preanalytical Processes for Patient Safety 2Managing Preanalytical Processes for Patient Safety 3Managing Preanalytical Processes for Patient Safety 4
Shafts angled 8 mm from tip to bend with smooth jaws. Flat, cross action handle with holes and dull finish.
Designed to accurately fold most flexible intraocular lens for ease of grasping with the folding instruments. The notched jaws align the implant and position it for a precise fold. Ideal for lens dia
Biconvex jaw design. 40 degree angled shafts. Tip to angle length: 7.5 mm. Locking handle. Manufacturing in titanium.
45 degree. Angled shafts. Tip to angle length: 11.5 mm. Stops in handle designed to prevent "over folding". Manufactured in titanium.
Medicine Products: